Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BSA-based vs Standard Mycophenolate Dosing in Kidney Transplant
NCT04473924Phase 2Withdrawn
- Sponsor
- University of California, San Francisco
- Start
- Jul 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mycophenolate mofetil in kidney transplant rejection, sponsored by University of California, San Francisco. Planned start Jul 2022; status: withdrawn.
02
Drugs
mycophenolate mofetil
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT04473924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04473924.